Follow-Up: Ketamine Interaction, Higher Potency Cannabis Risk, Autism The latest scientific findings have shed light on the role of the cannabinoid receptor in reducing negative ketamine side effects,...
Ilesol Pharmaceuticals Launches Three New Skincare Products Ilesol Pharmaceuticals has launched three new skincare products as a part of our Skin Greens collection. The new products are Skin...
CBD Will Soon Be Available in Canadian Pharmacies and Vet Clinics CBD is safe and tolerable for short-term use for a maximum of 30 days at a maximum dose of 200 mg/day through oral administration,...
EFSA Clarified Data Gaps for Novel Food Registration On 28th June 2022, the European Industrial Hemp Association (EIHA) representatives joined the info-session organized by the Europe...
Topical CBD for the Treatment of Basal Thumb Arthritis The first human study on the efficacy of topical CBD for the treatment of thumb basal joint arthritis-related pain published in Ma...
EFSA: CBD Novel Food Evaluations on Hold Pending New Data On June 7, 2022, the European Fooda Safety Authority (EFSA) published a statement summarising the state of knowledge on the safety...
CBD in the UK: Over 60% Mislabeled, Controlled Substances Found As was the case in other countries, over-the-counter CBD products in the UK have proved to be substandard. A recent analysis of 29...
Even the Dose of 1500mg CBD Doesn’t Affect Driving New research from the University of Sydney has found that even 1500mg, the highest daily medicinal dose of cannabidiol (CBD), has...
CBD From Non-Cannabis Plants: Myth or Reality? Legal issues surrounding synthetic CBD and cannabis generally have led scientists to attempt the identification of an alternative...
